Efficacy of low-dose radioablation therapy using 740 MBq of I131 in postoperative differentiated thyroid cancer patients. An Initial Experience

被引：0
|
作者：
Iordanidou, L. [1 ]
Papadouli, D. [1 ]
Sevaslidou, I. [1 ]
Trekla, S. [1 ]
Erifillidou, M. [1 ]
Pateniotis, K. [1 ]
Trivizaki, E. [1 ]
机构：
[1] Metaxa Canc Hosp, Piraeus, Greece
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P0460
引用
收藏
页码：S447 / S447
页数：1
相关论文
共 50 条
  • [1] Efficacy of Low-Dose I-131 Therapy for the Postoperative Ablation of Low-Risk Differentiated Thyroid Cancer Patients
    Caglar, M.
    Bozkurt, F.
    Kapulu, C.
    Ugur, O.
    Bayraktar, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S344 - S344
  • [2] Is 740 MBq of iodine 131 (131I) an ablative dose for thyroid remnants, after total thyroidectomy for low risk group patients with differentiated thyroid cancer ?
    Cuif-Job, A.
    Fieffe, S.
    Kere, D.
    Wernert, R.
    Pochart, J.
    Schvartz, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S222 - S223
  • [3] Efficacy of I131 ablation therapy using different doses as determined by postoperative thyroid scan uptake in patients with differentiated thyroid cancer
    Zidan, J
    Hefer, E
    Iosilevski, G
    Drumea, K
    Stein, ME
    Kuten, A
    Israel, O
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (05): : 1330 - 1336
  • [4] Predictive factors for the outcomes of initial I-131 low-dose ablation therapy to Japanese patients with differentiated thyroid cancer
    Ito, Shinji
    Iwano, Shingo
    Kato, Katsuhiko
    Naganawa, Shinji
    ANNALS OF NUCLEAR MEDICINE, 2018, 32 (06) : 418 - 424
  • [5] Predictive factors for the outcomes of initial I-131 low-dose ablation therapy to Japanese patients with differentiated thyroid cancer
    Shinji Ito
    Shingo Iwano
    Katsuhiko Kato
    Shinji Naganawa
    Annals of Nuclear Medicine, 2018, 32 : 418 - 424
  • [6] Low Dose (1850 MBq) Versus High Dose (3700 MBq) of 131I in Ablation Therapy of Thyroid Remnants in Patients with Low Risk Differentiated Thyroid Carcinoma
    Andres Gracia, A.
    Rambalde Pecheco, E.
    Tardin Cardoso, L.
    Ayala Perez, S.
    Razola Alba, P.
    Cancer Garza, L.
    Lopez Acosta, M.
    Prats Rivera, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S537 - S537
  • [7] Comparison of efficacy of 2 220 MBq versus 3 700 MBq I-131 for ablation of thyroid remnant in patients with differentiated thyroid cancer
    Fish, S. A.
    Basu, S.
    Alavi, A.
    Mandel, S. J.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 54 (05): : 560 - 563
  • [8] Efficacy and tolerability of initial low-dose lenvatinib to treat differentiated thyroid cancer
    Yamazaki, Haruhiko
    Iwasaki, Hiroyuki
    Takasaki, Hirotaka
    Suganuma, Nobuyasu
    Sakai, Rika
    Masudo, Katsuhiko
    Nakayama, Hirotaka
    Rino, Yasushi
    Masuda, Munetaka
    MEDICINE, 2019, 98 (10)
  • [9] Low Versus High Dose 131I Radioablation In Postsurgical Management of Differentiated Thyroid Carcinoma Patients
    Urhan, M.
    Mavi, A.
    Fish, S.
    Houseni, M.
    Alavi, A.
    Mandel, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S241 - S241
  • [10] COMPARISON OF 1073-MBQ AND 3700-MBQ I-131 IN POSTOPERATIVE ABLATION OF RESIDUAL THYROID-TISSUE IN PATIENTS WITH DIFFERENTIATED THYROID-CANCER
    JOHANSEN, K
    WOODHOUSE, NJY
    ODUGBESAN, O
    JOURNAL OF NUCLEAR MEDICINE, 1991, 32 (02) : 252 - 254
12345